313 related articles for article (PubMed ID: 11889080)
1. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
3. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
5. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
6. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
8. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
[TBL] [Abstract][Full Text] [Related]
10. Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines.
Kato M; Nagaya T; Fujieda M; Saito K; Yoshida J; Seo H
Jpn J Cancer Res; 2002 Jun; 93(6):660-6. PubMed ID: 12079514
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
12. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
13. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
[TBL] [Abstract][Full Text] [Related]
15. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
17. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
18. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
